Search by Drug Name or NDC

    NDC 68047-0753-30 Butalbital and Acetaminophen 325; 25 mg/1; mg/1 Details

    Butalbital and Acetaminophen 325; 25 mg/1; mg/1

    Butalbital and Acetaminophen is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Larken Laboratories, Inc.. The primary component is ACETAMINOPHEN; BUTALBITAL.

    Product Information

    NDC 68047-0753
    Product ID 68047-753_0771bcff-6b38-c003-e063-6294a90a32a8
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Butalbital and Acetaminophen
    Proprietary Name Suffix n/a
    Non-Proprietary Name butalbital and acetaminophen
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 325; 25
    Active Ingredient Units mg/1; mg/1
    Substance Name ACETAMINOPHEN; BUTALBITAL
    Labeler Name Larken Laboratories, Inc.
    Pharmaceutical Class Barbiturate [EPC], Barbiturates [CS]
    DEA Schedule CIII
    Marketing Category ANDA
    Application Number ANDA203484
    Listing Certified Through 2024-12-31

    Package

    NDC 68047-0753-30 (68047075330)

    NDC Package Code 68047-753-30
    Billing NDC 68047075330
    Package 30 TABLET in 1 BOTTLE (68047-753-30)
    Marketing Start Date 2022-07-18
    NDC Exclude Flag N
    Pricing Information N/A